Respiratory syncytial virus (RSV) has been known to cause a rash in addition to the more common symptoms of a runny nose, coughing, and wheezing. However, an RSV rash is rare. This article explores ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be hospitalized in the U.S. The Respiratory Syncytial Virus is an ...

Respiratory syncytial virus (RSV) is a common, highly contagious illness that affects the nose, throat, and lungs. Although RSV usually causes mild illness with cold-like symptoms, the infection can ...

As the chill of winter sets in, fears are mounting over a potential 'tripledemic' surge in Covid-19, flu and respiratory syncytial virus (RSV) cases. Health officials in Northern Ireland have ...

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c01113. PDB files of synthesized photopeptides in complex ...

The Centers for Disease Control and Prevention warned in October that both RSV and walking pneumonia — a mild but very contagious illness — are on the rise, especially among very young kids.

全球首家公布RSV候选疫苗与已获批重磅RSV疫苗头对头临床试验结果、且结果积极的厂家，来自中国。 当开年至今无一款国产创新型疫苗获批上市 ...

For the company’s closely watched respiratory syncytial virus (RSV) vaccine Arexvy, those challenges led to drastically reduced sales. After a stunning ascension to blockbuster status in its RSV ...

GSK CEO Emma Walmsley's bet on blockbuster RSV vaccine, Arexvy, has hit a snag in recent months after the U.S. public health agency narrowed the age recommendation for use of RSV vaccines and ...

But which ones should you get? This year marks the second season for the new respiratory syncytial virus vaccine (RSV) for grown-ups. While not everyone needs it, the evidence so far suggests that ...

Arexvy was the first vaccine for RSV, a flu-like illness, to be approved by the US Food and Drug Administration in 2023. The inoculation quickly established a market-leading position over Pfizer ...